RETROSPECTIVE STUDY OF MORBIDITY AND MORTALITY OF AFRICAN PENGUINS (SPHENISCUS DEMERSUS) UNDER MANAGED CARE IN NORTH AMERICA: 2007-2018

EVALUATION OF MORTALITY CAUSES AND PREVALENCE OF RENAL LESIONS IN ZOO-HOUSED CHAMELEONS: 2011-2022

Of the 202 species of Chamaeleonidae, 38.6% are globally threatened. Currently, nearly a thousand individual chameleons from 36 different species are kept in zoological institutions worldwide. The objectives of this study were to assess the main mortality causes of chameleons in zoological institutions, the prevalence of renal lesions at necropsy, and the environmental factors associated with renal lesions. An online survey was sent to 245 zoological institutions worldwide to collect information about species and sex distribution, necropsy results, and husbandry parameters. Necropsy reports of the last 10 yr were requested from participating institutions (n = 65) when available. Mortality causes were classified into three categories (open diagnosis, infectious, and noninfectious), and noninfectious causes were further subdivided into seven categories (renal, reproductive, myoarthroskeletal, digestive, ophthalmologic, denutrition/multisystemic, and neoplastic). The prevalence of renal lesions was recorded. Multiple linear regression models were used with the prevalence of renal diseases as the dependent variable, and exhibit minimum and maximum hygrometry; exhibit highest and coolest temperature; as well as minimum, mean, and maximum hygrometry of the geographical area as independent variables, combining all chameleon species with similar environmental requirements. Results were obtained for 14 species (n = 412 individuals). The main mortality causes were infectious (46.8%), noninfectious renal (11.4%), and noninfectious reproductive (10.7%) diseases, with all cases of fatal reproductive diseases reported in females. Of the individuals that underwent renal histopathology, 41.7% displayed renal lesions. There was a tendency towards higher renal lesion prevalence in zoos located in areas with lower mean hygrometry (P = 0.05). Further research studies about infectious, renal, and reproductive diseases of Chamaeleonidae are warranted.

Nationwide Survey about the Occurrence of Aspergillosis in Captive Penguins in Zoos and Aquariums in Japan

We surveyed the facilities that were members of the Japan Association of Zoos and Aquariums to clarify the incidence of aspergillosis, which is a major cause of death in captive penguins, and to discern effective preventive measures. Responses were obtained for 2910 penguins in 64 facilities; 73 penguins (2.5%) in 35 facilities had died from aspergillosis during the past 5 years from April 2016 to March 2021. Answers to questions about the rearing environment indicated that aspergillosis occurred significantly more often in facilities where penguins were reared outdoors, were in contact with soil, or were moved outside of the rearing enclosure. Answers to questions about their dead penguins indicated that 76% may have been at individual risk (e.g., young age, old age, molting period, and breeding season) and 54% were thought to be reared in uncomfortable environments (e.g., high temperature, high humidity). Aspergillosis may occur when individual risk factors and uncomfortable environmental factors are added to the risk factors of exposure to Aspergillus, such as the presence of soil. These conditions must be recognized as risk factors for aspergillosis, and appropriate preventive measures, such as avoiding penguin contact with the soil where Aspergillus is expected to be present, can minimize aspergillosis-related deaths.

Assessment of the Safety and Efficacy of an Oral Probiotic-Based Vaccine Against Aspergillus Infection in Captive-Bred Humboldt Penguins (Spheniscus humboldti)

Aspergillosis is a fungal infection caused mainly by Aspergillus fumigatus that often results in respiratory disease in birds. Aspergillosis is a major cause of morbidity and mortality in captive-bred penguin species. Currently, there is no registered vaccine to prevent aspergillosis. Recent research demonstrated that oral administration of gram-negative bacteria expressing high levels of galactose-α-1,3-galactose (α-Gal) modulates anti-α-Gal immunity and protects turkeys from clinical aspergillosis caused by experimental A. fumigatus infection. The role of anti-α-Gal immunity in penguins has not been studied. Here, we tested the distribution of α-1,3-galactosyltransferase (α1,3GT) genes in the fecal microbiome of Humboldt penguins (Spheniscus humboldti). The occurrence of natural anti-α-Gal antibodies (Abs) in sera and eggs of healthy Humboldt penguins was also assessed. A trial was then conducted to test whether oral administration of Escherichia coli Nissle, expressing high α-Gal levels, modulates anti-α-Gal immunity in a colony of Humboldt penguins. Animals in the vaccination and placebo groups were evaluated before the trial and followed for one year for aspergillosis detection using a diagnostic panel including computed tomography scans, capillary zone electrophoresis, 3-hydroxybutyrate levels, and anti-A. fumigatus Abs. Anti-α-Gal Abs were detected in sera (IgM and IgY) and eggs (IgY) of healthy penguins. Microbiota analysis and functional predictions revealed the presence of α1,3GT genes in the microbiota of Humboldt penguins and other penguin species. A strong decrease in anti-α-Gal IgM levels was observed in all animals in the placebo group three months after vaccination protocol. This decrease was not observed in E. coli Nissle-treated penguins. After the vaccination protocol, we found a positive correlation between anti-E. coli IgY and anti-α-Gal IgY in the E. coli Nissle group, suggesting a correlation between the presence of the bacteria and these Abs. During the study period, three penguins exhibited respiratory signs consistent with aspergillosis. Two were from the placebo group whose symptoms resolved with specific treatments, while a single vaccinated individual developed fatal respiratory aspergillosis eight months after the trial. We conclude that E. coli Nissle represents a safe potential probiotic with a protective effect against aspergillosis in Humboldt penguins that deserves to be further explored for therapeutic uses in these animals.